1479-5876

Journal of Translational Medicine

Springer (Biomed Central Ltd.)

Health Score

0 Good

Metadata coverage

Abstract
ORCID
References
License

Extended metadata coverage

Informational — signals of interoperability and funding across the corpus. Not part of the health score.

Funding

Funder
Award / grant

Affiliation & institutional identifiers

Affiliation
ROR ID

Update policy

Update policy

Your prioritized action plan

Ordered by how many DOIs each fix touches — start here, not with every error at once.

1

Add abstracts to 5658 articles

Abstracts are what surface your work in Google Scholar, Dimensions, and OpenAlex.

High impact5658 DOIs
2

Attach ORCID iDs across 5246 articles

ORCID iDs strengthen author disambiguation and institutional reporting.

High impact5246 DOIs
3

Add license metadata to 2057 records

License metadata tells indexers and readers how each article may be reused.

Low impact2057 DOIs

DOIs for this ISSN

Showing the top 5 of 10000 DOIs, ordered by correction priority.

# Title Missing Priority Citations
1 Translational Medicine: A two-way road (10.1186/1479-5876-1-1)
Abstract References ORCID License
229.89 198
2 Milk: an exosomal microRNA transmitter promoting thymic regu… (10.1186/1479-5876-12-43)
Abstract References ORCID License
217.90 150
3 LPS-preconditioned mesenchymal stromal cells modify macropha… (10.1186/s12967-015-0642-6)
Abstract ORCID License
208.90 609
4 Recent advances in bioprinting techniques: approaches, appli… (10.1186/s12967-016-1028-0)
Abstract ORCID License
202.29 497
5 Donor age negatively impacts adipose tissue-derived mesenchy… (10.1186/1479-5876-12-8)
Abstract ORCID License
199.35 454
6 Placenta-derived exosomes continuously increase in maternal… (10.1186/1479-5876-12-204)
Abstract ORCID License
193.14 375
7 Immune modulation of some autoimmune diseases: the critical… (10.1186/s12967-017-1141-8)
Abstract ORCID License
187.99 320
8 Short and long term health effects of parental tobacco smoki… (10.1186/s12967-015-0690-y)
Abstract ORCID License
186.75 308
9 Intra-articular injection of two different doses of autologo… (10.1186/s12967-016-0998-2)
Abstract ORCID License
184.00 283
10 Increased number of circulating exosomes and their microRNA… (10.1186/s12967-015-0623-9)
Abstract ORCID License
181.87 265
11 Changing R&D models in research-based pharmaceutical com… (10.1186/s12967-016-0838-4)
Abstract ORCID License
181.62 263
12 Association of cancer metabolism-related proteins with oral… (10.1186/1479-5876-12-208)
Abstract References ORCID License
180.62 63
13 Effects of surgery and anesthetic choice on immunosuppressio… (10.1186/s12967-018-1389-7)
Abstract ORCID License
180.62 255
14 Low-dose temozolomide before dendritic-cell vaccination redu… (10.1186/1479-5876-11-135)
Abstract References ORCID License
179.93 62
15 The clinical utility of bone marker measurements in osteopor… (10.1186/1479-5876-11-201)
Abstract ORCID License
179.85 249
16 Gamma-delta (γδ) T cells: friend or foe in cancer developmen… (10.1186/s12967-017-1378-2)
Abstract ORCID License
179.58 247
17 Insulin-like growth factor-1 deficiency and metabolic syndro… (10.1186/s12967-015-0762-z)
Abstract ORCID License
179.32 245
18 Phase I clinical trial of autologous NK cell therapy using n… (10.1186/s12967-015-0632-8)
Abstract ORCID License
177.83 234
19 Dietary hyperoxaluria is not reduced by treatment with lacti… (10.1186/1479-5876-11-306)
Abstract References ORCID License
174.82 55
20 Immunocompetent murine models for the study of glioblastoma… (10.1186/1479-5876-12-107)
Abstract ORCID License
174.01 208
21 Gemcitabine reduces MDSCs, tregs and TGFβ-1 while restoring… (10.1186/s12967-016-1037-z)
Abstract ORCID License
173.38 204
22 Bronchopulmonary dysplasia: clinical aspects and preventive… (10.1186/s12967-018-1417-7)
Abstract ORCID License
173.22 203
23 Taurine: the appeal of a safe amino acid for skeletal muscle… (10.1186/s12967-015-0610-1)
Abstract ORCID License
172.90 201
24 Circulating microRNAs as biomarkers for diffuse myocardial f… (10.1186/s12967-015-0672-0)
Abstract ORCID License
172.74 200
25 New perspective in diagnostics of mitochondrial disorders: t… (10.1186/s12967-016-0930-9)
Abstract ORCID License
172.25 197
26 Systemic immune-inflammation index predicting chemoradiation… (10.1186/s12967-017-1326-1)
Abstract ORCID License
170.21 185
27 Long noncoding RNA dysregulation in ischemic heart failure (10.1186/s12967-016-0926-5)
Abstract ORCID License
168.23 174
28 Triglyceride glucose-waist circumference, a novel and effect… (10.1186/s12967-016-1020-8)
Abstract ORCID License
167.66 171
29 The Apoe−/− mouse model: a suitable model to study cardiovas… (10.1186/s12967-016-0901-1)
Abstract ORCID License
167.09 168
30 The pathophysiological role of mitochondrial oxidative stres… (10.1186/s12967-017-1306-5)
Abstract ORCID License
166.90 167
31 Quantification of tumour budding, lymphatic vessel density a… (10.1186/1479-5876-12-156)
Abstract References ORCID License
166.28 45
32 Flow diverter effect of LVIS stent on cerebral aneurysm hemo… (10.1186/s12967-016-0959-9)
Abstract ORCID License
166.11 163
33 Tumor infiltrating B-cells are increased in prostate cancer… (10.1186/1479-5876-12-30)
Abstract ORCID License
164.69 156
34 Exosomes in tumor microenvironment: novel transporters and b… (10.1186/s12967-016-1056-9)
Abstract ORCID License
163.64 151
35 Combined PD-1 blockade and GITR triggering induce a potent a… (10.1186/1479-5876-12-36)
Abstract ORCID License
162.77 147
36 A potential signature of eight long non-coding RNAs predicts… (10.1186/s12967-015-0556-3)
Abstract ORCID License
162.55 146
37 Mesenchymal stem cells and their secreted molecules predomin… (10.1186/s12967-016-0792-1)
Abstract ORCID License
162.33 145
38 Adipose-derived regenerative cell (ADRC)-enriched fat grafti… (10.1186/1479-5876-11-254)
Abstract References ORCID License
162.32 41
39 Clinical experience with ipilimumab 3 mg/kg: real-world effi… (10.1186/1479-5876-12-116)
Abstract ORCID License
162.10 144
40 Profiling and bioinformatics analyses reveal differential ci… (10.1186/s12967-016-0977-7)
Abstract ORCID License
161.88 143
41 Cariporide and other new and powerful NHE1 inhibitors as pot… (10.1186/1479-5876-11-282)
Abstract ORCID License
161.65 142
42 Phase I clinical study of anti-apoptosis protein, survivin-d… (10.1186/1479-5876-2-19)
Abstract ORCID License
161.65 142
43 MiR-106b induces cell radioresistance via the PTEN/PI3K/AKT… (10.1186/s12967-015-0592-z)
Abstract ORCID License
160.73 138
44 Lost in Translation: Obstacles to Translational Medicine (10.1186/1479-5876-2-14)
Abstract ORCID License
160.25 136
45 Successful adoptive transfer and in vivo expansion of haploi… (10.1186/1479-5876-12-45)
Abstract ORCID License
160.02 135
46 Step-up fecal microbiota transplantation strategy: a pilot s… (10.1186/s12967-015-0646-2)
Abstract ORCID License
159.78 134
47 Obesity and colorectal cancer: molecular features of adipose… (10.1186/s12967-016-0772-5)
Abstract ORCID License
159.29 132
48 Prediction of anti-inflammatory proteins/peptides: an insili… (10.1186/s12967-016-1103-6)
Abstract ORCID License
158.80 130
49 IL-37 inhibits the production of inflammatory cytokines in p… (10.1186/1479-5876-12-69)
Abstract ORCID License
158.04 127
50 Clinical-scale expansion of mesenchymal stromal cells: a lar… (10.1186/s12967-016-0892-y)
Abstract ORCID License
158.04 127